DG vs VNDA · P/E 15, rev $22.08B vs rev $102.2M
Dollar General Corporation (DG) versus Vanda Pharmaceuticals Inc (VNDA) — a side-by-side from cached financials, not a winner call.
Dollar General Corporation (DG) is a discount stores company listed on US.
Vanda Pharmaceuticals Inc (VNDA) is a biotechnology company listed on NASDAQ.
Latest reported DG revenue for 2026-07-31 was $22.08B. Net income was $994.4M. DG currently screens at market cap $22.87B and trailing P/E 14.7.
Latest reported VNDA revenue for 2026-06-30 was $102.2M. Net income was -$111.1M. Revenue was up 97.7% from 2026-03-31 to 2026-06-30. VNDA currently screens at market cap $358.4M.
DG currently screens at market cap $22.87B and trailing P/E 14.7. VNDA currently screens at market cap $358.4M.
Not investment advice. Open the DG and VNDA stock pages for the full models.
Not investment advice.